197 related articles for article (PubMed ID: 31570308)
1. Improving the clinical understanding of hypertrophic cardiomyopathy by combining patient data, machine learning and computer simulations: A case study.
Lyon A; Mincholé A; Bueno-Orovio A; Rodriguez B
Morphologie; 2019 Dec; 103(343):169-179. PubMed ID: 31570308
[TBL] [Abstract][Full Text] [Related]
2. Electrocardiogram phenotypes in hypertrophic cardiomyopathy caused by distinct mechanisms: apico-basal repolarization gradients vs. Purkinje-myocardial coupling abnormalities.
Lyon A; Bueno-Orovio A; Zacur E; Ariga R; Grau V; Neubauer S; Watkins H; Rodriguez B; Mincholé A
Europace; 2018 Nov; 20(suppl_3):iii102-iii112. PubMed ID: 30476051
[TBL] [Abstract][Full Text] [Related]
3. The China Hypertrophic Cardiomyopathy Project (CHCMP): The Rationale and Design of a Multicenter, Prospective, Registry Cohort Study.
Du Z; Wang K; Cui Y; Xie X; Zhu R; Dong F; Guo X
J Cardiovasc Transl Res; 2024 Jun; 17(3):732-738. PubMed ID: 38180696
[TBL] [Abstract][Full Text] [Related]
4. Hypertrophic cardiomyopathy: an updated review on diagnosis, prognosis, and treatment.
Makavos G; Κairis C; Tselegkidi ME; Karamitsos T; Rigopoulos AG; Noutsias M; Ikonomidis I
Heart Fail Rev; 2019 Jul; 24(4):439-459. PubMed ID: 30852773
[TBL] [Abstract][Full Text] [Related]
5. Disease Severity and Exercise Testing Reduce Subcutaneous Implantable Cardioverter-Defibrillator Left Sternal ECG Screening Success in Hypertrophic Cardiomyopathy.
Srinivasan NT; Patel KH; Qamar K; Taylor A; Bacà M; Providência R; Tome-Esteban M; Elliott PM; Lambiase PD
Circ Arrhythm Electrophysiol; 2017 Apr; 10(4):. PubMed ID: 28408651
[TBL] [Abstract][Full Text] [Related]
6. Appropriate and inappropriate shocks in hypertrophic cardiomyopathy patients with subcutaneous implantable cardioverter-defibrillators: An international multicenter study.
Nazer B; Dale Z; Carrassa G; Reza N; Ustunkaya T; Papoutsidakis N; Gray A; Howell SJ; Elman MR; Pieragnoli P; Ricciardi G; Jacoby D; Frankel DS; Owens A; Olivotto I; Heitner SB
Heart Rhythm; 2020 Jul; 17(7):1107-1114. PubMed ID: 32084597
[TBL] [Abstract][Full Text] [Related]
7. Implantable cardioverter defibrillator therapy and sudden death risk stratification in hypertrophic cardiomyopathy patients with midventricular obstruction: A single-center experience.
Maeda R; Minami Y; Haruki S; Kanbayashi K; Itani R; Suzuki A; Ejima K; Shiga T; Shoda M; Hagiwara N
Int J Cardiol; 2016 Jul; 214():419-22. PubMed ID: 27088403
[TBL] [Abstract][Full Text] [Related]
8. Validation of the 2014 European Society of Cardiology guidelines risk prediction model for the primary prevention of sudden cardiac death in hypertrophic cardiomyopathy.
Vriesendorp PA; Schinkel AF; Liebregts M; Theuns DA; van Cleemput J; Ten Cate FJ; Willems R; Michels M
Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):829-35. PubMed ID: 25922410
[TBL] [Abstract][Full Text] [Related]
9. The T-peak-to-T-end interval: a novel ECG marker for ventricular arrhythmia and appropriate ICD therapy in patients with hypertrophic cardiomyopathy.
Dinshaw L; Münch J; Dickow J; Lezius S; Willems S; Hoffmann BA; Patten M
Clin Res Cardiol; 2018 Feb; 107(2):130-137. PubMed ID: 28965260
[TBL] [Abstract][Full Text] [Related]
10. Sudden cardiac arrest in a young patient with hypertrophic cardiomyopathy and zero canonical risk factors: the inherent limitations of risk stratification in hypertrophic cardiomyopathy.
Kohorst JJ; Bos JM; Hagler DJ; Ackerman MJ
Congenit Heart Dis; 2014; 9(2):E51-7. PubMed ID: 23648018
[TBL] [Abstract][Full Text] [Related]
11. Evolution of risk stratification and sudden death prevention in hypertrophic cardiomyopathy: Twenty years with the implantable cardioverter-defibrillator.
Maron BJ; Rowin EJ; Maron MS
Heart Rhythm; 2021 Jun; 18(6):1012-1023. PubMed ID: 33508516
[TBL] [Abstract][Full Text] [Related]
12. Paradigm of Sudden Death Prevention in Hypertrophic Cardiomyopathy.
Maron BJ; Rowin EJ; Maron MS
Circ Res; 2019 Aug; 125(4):370-378. PubMed ID: 31518168
[TBL] [Abstract][Full Text] [Related]
13. A simple algorithm for a clinical step-by-step approach in the management of hypertrophic cardiomyopathy.
Efthimiadis G; Zegkos T; Parcharidou D; Ntelios D; Panagiotidis T; Gossios T; Karvounis H
Future Cardiol; 2021 Nov; 17(8):1395-1405. PubMed ID: 33615852
[TBL] [Abstract][Full Text] [Related]
14. Primary prevention implantable cardioverter-defibrillators in hypertrophic cardiomyopathy-Are there predictors of appropriate therapy?
Weissler-Snir A; Dorian P; Rakowski H; Care M; Spears D
Heart Rhythm; 2021 Jan; 18(1):63-70. PubMed ID: 32800967
[TBL] [Abstract][Full Text] [Related]
15. ESC sudden-death risk model in hypertrophic cardiomyopathy: Incremental value of quantitative contrast-enhanced CMR in intermediate-risk patients.
Hinojar R; Zamorano JL; Gonzalez Gómez A; Plaza Martin M; Esteban A; Rincón LM; Portugal JC; Jimenez Nácher JJ; Fernández-Golfín C
Clin Cardiol; 2017 Oct; 40(10):853-860. PubMed ID: 28614597
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of subcutaneous implantable cardioverter-defibrillator candidacy based on template ECG screening in patients with hypertrophic cardiomyopathy.
Maurizi N; Olivotto I; Olde Nordkamp LR; Baldini K; Fumagalli C; Brouwer TF; Knops RE; Cecchi F
Heart Rhythm; 2016 Feb; 13(2):457-63. PubMed ID: 26362577
[TBL] [Abstract][Full Text] [Related]
17. Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators.
Maron BJ; Casey SA; Olivotto I; Sherrid MV; Semsarian C; Autore C; Ahmed A; Boriani G; Francia P; Winters SL; Giudici M; Koulova A; Garberich R; Rowin EJ; Sears SF; Maron MS; Spirito P
Circ Arrhythm Electrophysiol; 2018 Apr; 11(4):e005820. PubMed ID: 29625970
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and risk stratification in hypertrophic cardiomyopathy using machine learning wall thickness measurement: a comparison with human test-retest performance.
Augusto JB; Davies RH; Bhuva AN; Knott KD; Seraphim A; Alfarih M; Lau C; Hughes RK; Lopes LR; Shiwani H; Treibel TA; Gerber BL; Hamilton-Craig C; Ntusi NAB; Pontone G; Desai MY; Greenwood JP; Swoboda PP; Captur G; Cavalcante J; Bucciarelli-Ducci C; Petersen SE; Schelbert E; Manisty C; Moon JC
Lancet Digit Health; 2021 Jan; 3(1):e20-e28. PubMed ID: 33735065
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Implication of First-Degree Atrioventricular Block in Patients With Hypertrophic Cardiomyopathy.
Higuchi S; Minami Y; Shoda M; Shirotani S; Saito C; Haruki S; Gotou M; Yagishita D; Ejima K; Hagiwara N
J Am Heart Assoc; 2020 Mar; 9(6):e015064. PubMed ID: 32146896
[TBL] [Abstract][Full Text] [Related]
20. Identification of Myocardial Disarray in Patients With Hypertrophic Cardiomyopathy and Ventricular Arrhythmias.
Ariga R; Tunnicliffe EM; Manohar SG; Mahmod M; Raman B; Piechnik SK; Francis JM; Robson MD; Neubauer S; Watkins H
J Am Coll Cardiol; 2019 May; 73(20):2493-2502. PubMed ID: 31118142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
